Drug intelligence / Profile preview

mumps vaccine, live

Development stage
Approved
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Mumps vaccine, live is a live-attenuated viral vaccine used for active immunization against mumps. It contains a weakened strain of the mumps virus, such as the Jeryl Lynn strain, which replicates in the recipient to induce a long-lasting immune response without causing the disease. While most commonly administered as part of the trivalent MMR (measles, mumps, and rubella) vaccine, monovalent formulations are produced by companies like Sinovac (Dalian) Vaccine Technology for use in specific populations, such as junior high school entrants or infants. Beyond its primary use in infectious disease prevention, research has explored its potential as an oncolytic agent in cancers like ovarian cancer due to its ability to induce cell fusion and death in malignant cells.

Brand names
M-M-R IIProQuadMumpsvax
Other names
live attenuated mumps vaccineJeryl Lynn strain mumps vaccinemumps vaccine (live)

Beyond the preview

Go deeper on mumps vaccine, live.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mumps vaccine, live.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call